J.P. Morgan Maintains Beckman Coulter Overweight Rating

Loading...
Loading...
As sentiment remains negative on Beckman Coulter, Inc.
BEC
, J.P. Morgan said that it remains Overweight on shares of BEC. “Despite a short-covering rally following Q3 results, sentiment remains generally bearish based on our conversations with investors,” J.P. Morgan writes. “We continue to like the stock with the view toward the end of next year (December 2011 price target: $62, unchanged), though we acknowledge that there are unlikely to be near-term catalysts (a new CEO is likely three to six months away, and 2011 guidance won't come until February).” Beckman Coulter closed Friday at $55.15.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst Ratingsbeckman coulterHealth CareHealth Care EquipmentJ.P. Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...